Capital DailyCapital Daily
Markets · Investing · Business
Capital DailyCapital Daily
Finance

Here's the Cannabis Stock With the Most to Gain From Trump's Marijuana Rescheduling Push

This cannabis company is not like the others.

Here's the Cannabis Stock With the Most to Gain From Trump's Marijuana Rescheduling Push

Published July 31, 2026 · Category: Finance

Overview

President Trump showed support for looser regulations in the cannabis industry even before he was elected for his second term in office. For instance, he supported an initiative in his home state of Florida that aimed at making recreational use of marijuana legal for adults. And since he took office for his second term, there has been significant progress in the industry. Products containing marijuana approved by the U.S. Food and Drug Administration -- as well as medical marijuana products regulated at the state level -- are now deemed Schedule III substances, when they were previously in the Schedule I category.

Recently, there was also a hearing to consider moving even more cannabis products into Schedule III. These changes may have a wide-ranging impact on the industry, and one company that could benefit the most is Green Thumb Industries (OTC: GTBIF). Here is why.

Image source: The White House.

Details

Continue reading

Source

Originally published at www.fool.com.

Related Articles

CD
Capital Daily Newsroom

Capital Daily covers markets, crypto and commodities for Asia & the Middle East — tier-1 desk research, AI-driven analysis, institutional-grade data. Tip our newsroom: [email protected]

Email the newsroom →
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.